Skip to main content

Table 6 Comparison of the efficacy of different imaging modalities in the diagnosis of csPCa

From: The combined value of mpUS and mpMRI-TRUS fusion for the diagnosis of clinically significant prostate cancer

 

AUC(95% CI)

SE

Sen

Spe

YI

PPV

NPV

Z

P

mpMRI-TRUS

0.719

(0.652 ~ 0.780)

0.0313

80.95%

62.89%

43.84%

70.20%

75.30%

7.007

p < 0.001

mpUS

0.739

(0.672 ~ 0.798)

0.0304

83.81%

63.92%

47.73%

71.50%

78.50%

7.839

p < 0.001

mpMRI-mpUS*

0.770

(0.705 ~ 0.826)

0.0294

71.43%

82.47%

53.90%

81.50%

72.70%

9.153

p < 0.001

  1. *indicates a p value < 0.05 compared to mpMRI-TRUS